OARSI recommendations for the management of hip and knee osteoarthritis. Part III: Changes in evidence following systematic cumulative update of research published through January 2009.

Osteoarthritis and Cartilage

Volumn 18, Issue 4, 2010, Pages 476-499

  Zhang, W ^a   Nuki, G ^b   Moskowitz, R W ^c   Abramson, S ^d   Altman, R D ^e   Arden, N K ^f   Bierma Zeinstra, S ^g   Brandt, K D ^h   Croft, P ⁱ   Doherty, M ^a   Dougados, M ^j   Hochberg, M ^k   Hunter, D J ^l   Kwoh, K ^m   Lohmander, L S ⁿ   Tugwell, P ^o  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^d NYU HOSPITAL FOR JOINT DISEASES   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^g ERASMUS MEDICAL CENTER   (Netherlands)

^h INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ KEELE UNIVERSITY   (United Kingdom)

^j Paris ^*  (France)

^k UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^l UNIVERSITY OF SYDNEY   (Australia)

^m UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

ⁿ LUND UNIVERSITY   (Sweden)

^o UNIVERSITY OF OTTAWA   (Canada)

more..

Author keywords

Hip and knee osteoarthritis; New evidence; OARSI; Treatment guidelines

Indexed keywords

ALPHA TOCOPHEROL; CAPSAICIN; CELECOXIB; CHONDROITIN SULFATE; CODEINE; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; DEXTROPROPOXYPHENE; DIACETYLRHEIN; FENTANYL; GLUCOSAMINE; GLUCOSAMINE SULFATE; HISTAMINE H2 RECEPTOR ANTAGONIST; HYALURONIC ACID; IBUPROFEN; MISOPROSTOL; MORPHINE; MORPHINE SULFATE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OXYCODONE; OXYMORPHONE; PARACETAMOL; PIASCLEDINE; PLACEBO; PROTON PUMP INHIBITOR; ROFECOXIB; TRAMADOL; UNINDEXED DRUG; VALDECOXIB;

ACUPUNCTURE; ANALGESIA; ARTICLE; BALNEOTHERAPY; BLEEDING; CARDIOVASCULAR DISEASE; CINAHL; CLINICAL TRIAL; COCHRANE LIBRARY; CONSTIPATION; COST EFFECTIVENESS ANALYSIS; CRYOTHERAPY; DEBRIDEMENT; DIARRHEA; DIGESTIVE SYSTEM PERFORATION; DIGESTIVE SYSTEM ULCER; DIZZINESS; DRUG COST; DRUG MEGADOSE; DRUG WITHDRAWAL; ECONOMIC EVALUATION; ELECTROMAGNETIC RADIATION; EMBASE; EXERCISE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HEALTH EDUCATION; HEART INFARCTION; HIP OSTEOARTHRITIS; HOSPITALIZATION; HUMAN; HYDROTHERAPY; HYPERTHERMIC THERAPY; KIDNEY DISEASE; KIDNEY FAILURE; KNEE OSTEOARTHRITIS; LOW DRUG DOSE; LOW LEVEL LASER THERAPY; MAGNETOTHERAPY; MASSAGE; MEDICAL RESEARCH; MEDLINE; NAUSEA; PAIN; PEPTIC ULCER; PEPTIC ULCER BLEEDING; PERFORATION; PRIORITY JOURNAL; PUBLICATION; SELF CARE; SENSITIVITY ANALYSIS; SINGLE DRUG DOSE; SOMNOLENCE; SWELLING; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; TRANSCUTANEOUS NERVE STIMULATION; ULTRASOUND THERAPY; UNSPECIFIED SIDE EFFECT; VOMITING; WEIGHT REDUCTION;

EID: 77950021805     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2010.01.013     Document Type: Article

References (194)

1. Zhang W., Moskowitz R.W., Nuki G., Abramson S., Altman R.D., Arden N., et al. OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008, 16:137-162.
2. Zhang W., Moskowitz R.W., Nuki G., Abramson S., Altman R.D., Arden N., et al. OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage 2007, 15:981-1000.
3. Oxman A.D., Guyatt G.H. Validation of an index of the quality of review articles. J Clin Epidemiol 1991, 44:1271-1278.
4. Jadad A.R., Moore R.A., Carroll D., Jenkinson C., Reynolds D.J., Gavaghan D.J., et al. Assessing the quality of reports of randomised clinical trials: is blinding necessary?. Control Clin Trials 1996, 17:1-12.
5. Shekelle P.G., Woolf S.H., Eccles M., Grimshaw J. Clinical guidelines: developing guidelines. BMJ 1999, 318:593-596. (Review, 17 refs.).
6. Egger M., Davey S.G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
7. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21:1539-1558.
8. Osteoarthritis: national clinical guideline for care and management in adults 2008, National Collaborating Centre for Chronic Conditions, Royal College of Physicians, London, (Ref. type: report).
9. American Society of Orthopedic Surgeons Treatment of osteoarthritis of the knee (non-arthroplasty) http://www.aaos.org/research/guidelines/GuidelineOAKnee.asp.
10. Buszewicz M., Rait G., Griffin M., Nazareth I., Patel A., Atkinson A., et al. Self management of arthritis in primary care: randomised controlled trial. BMJ 2006, 333:879.
11. Chodosh J., Morton S.C., Mojica W., Maglione M., Suttorp M.J., Hilton L., et al. Meta-analysis: chronic disease self-management programs for older adults. Ann Intern Med 2005, 143:427-438.
12. Ravaud P., Flipo R.M., Boutron I., Roy C., Mahmoudi A., Giraudeau B., et al. ARTIST (osteoarthritis intervention standardized) study of standardised consultation versus usual care for patients with osteoarthritis of the knee in primary care in France: pragmatic randomised controlled trial. BMJ 2009, 338:b421.
13. Bartels E.M., Lund H., Hagen K.B., Dagfinrud H., Christensen R., Danneskiold-Samsoe B. Aquatic exercise for the treatment of knee and hip osteoarthritis. Cochrane Database Sys Rev 2007, CD005523.
14. Devos-Comby L., Cronan T., Roesch S.C. Do exercise and self-management interventions benefit patients with osteoarthritis of the knee? A meta-analytic review. J Rheumatol 2006, 33:744-756.
15. Hernandez-Molina G., Reichenbach S., Bin Z., Lavalley M., Felson D.T. Effect of therapeutic exercise for hip osteoarthritis pain: results of a meta-analysis. Arthritis Care Res 2008, 59:1221-1228.
16. Jamtvedt G., Dahm K.T., Christie A., Moe R.H., Haavardsholm E., Holm I., et al. Physical therapy interventions for patients with osteoarthritis of the knee: an overview of systematic reviews. Phys Ther 2008, 88:123-136.
17. Pisters M.F., Veenhof C., van Meeteren N.L., Ostelo R.W., de Bakker D.H., Schellevis F.G., et al. Long-term effectiveness of exercise therapy in patients with osteoarthritis of the hip or knee: a systematic review. Arthritis Rheum 2007, 57:1245-1253.
18. Ricci N.A., Coimbra I.B. Exercise therapy as a treatment in osteoarthritis of the hip: a review of randomized clinical trials. Rev Bras Reumatol 2006, 46:273-280. (Portuguese).
19. Walsh N.E., Mitchell H.L., Reeves B.C., Hurley M.V. Integrated exercise and self-management programmes in osteoarthritis of the hip and knee: a systematic review of effectiveness. Phys Ther Rev 2006, 11:289-297.
20. Roddy E., Zhang W., Doherty M. Aerobic walking or strengthening exercise for osteoarthritis of the knee? A systematic review. Ann Rheum Dis 2005, 64:544-548.
21. Christensen R., Bartels E.M., Astrup A., Bliddal H. Effect of weight reduction in obese patients diagnosed with knee osteoarthritis: a systematic review and meta-analysis. Ann Rheum Dis 2007, 66:433-439.
22. Kwon Y.D., Pittler M.H., Ernst E. Acupuncture for peripheral joint osteoarthritis: a systematic review and meta-analysis. Rheumatology 2006, 45:1331-1337.
23. Manheimer E., Linde K., Lao L., Bouter L.M., Berman B.M. Meta-analysis: acupuncture for osteoarthritis of the knee. Ann Intern Med 2007, 146:868-877.
24. Moe R.H., Haavardsholm E.A., Christie A., Jamtvedt G., Dahm K.T., Hagen K.B. Effectiveness of nonpharmacological and nonsurgical interventions for hip osteoarthritis: an umbrella review of high-quality systematic reviews. Phys Ther 2007, 87:1716-1727.
25. Vas J., White A. Evidence from RCTs on optimal acupuncture treatment for knee osteoarthritis - an exploratory review. Acupunct Med 2007, 25:29-35.
26. White A., Tough E., Cummings M. A review of acupuncture clinical trials indexed during 2005. Acupunct Med 2006, 24:39-49.
27. White A., Foster N., Cummings M., Barlas P. The effectiveness of acupuncture for osteoarthritis of the knee - a systematic review. Acupunct Med 2006, 24(Suppl 8).
28. White A., Foster N.E., Cummings M., Barlas P. Acupuncture treatment for chronic knee pain: a systematic review. Rheumatology 2007, 46:384-390.
29. Yamashita H., Masuyama S., Otsuki K., Tsukayama H. Safety of acupuncture for osteoarthritis of the knee - a review of randomised controlled trials, focusing on specific reactions to acupuncture. Acupunct Med 2006, 24:S49-S52.
30. Witt C., Selim D., Reinhold T., Jena S., Brinkhaus B., Liecker B., et al. Cost-effectiveness of acupuncture in patients with headache, low back pain and osteoarthritis of the hip and the knee. Altern Complement Ther 2005 2005, 10:57-58.
31. McCarthy C.J., Callaghan M.J., Oldham J.A. Pulsed electromagnetic energy treatment offers no clinical benefit in reducing the pain of knee osteoarthritis: a systematic review. BMC Musculoskelet Disord 2006, 51.
32. Towheed T.E., Maxwell L., Judd M.G., Catton M., Hochberg M.C., Wells G. Acetaminophen for osteoarthritis. Cochrane Database Syst Rev 2006, CD004257.
33. Zhang W., Jones A., Doherty M. Does paracetamol (acetaminophen) reduce the pain of osteoarthritis? A meta-analysis of randomised controlled trials. Ann Rheum Dis 2004, 63:901-907.
34. Herrero B.G., Ivorra J.A., Del Carmen T.M., Blanco F.J., Benito P., Martín M.E., et al. Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator. Arthritis Rheum 2007, 56:555-567.
35. Amadio P., Cummings D.M. Evaluation of acetaminophen in the management of osteoarthritis of the knee. Curr Ther Res 1983, 34:59-66.
36. Zoppi M., Peretti G., Boccard E. Placebo-controlled study of the analgesic efficacy of an effervescent formulation of 500mg paracetamol in arthritis of the knee or the hip. Eur J Pain 1995, 16:42-48.
37. Rahme E., Barkun A., Nedjar H., Gaugris S., Watson D. Hospitalizations for upper and lower GI events associated with traditional NSAIDs and acetaminophen among the elderly in Quebec, Canada. Am J Gastroenterol 2008, 103:872-882.
38. Curhan G.C., Knight E.L., Rosner B., Hankinson S.E., Stampfer M.J. Lifetime nonnarcotic analgesic use and decline in renal function in women. Arch Intern Med 2004, 164:1519-1524.
39. Curhan G.C., Willett W.C., Rosner B., Stampfer M.J. Frequency of analgesic use and risk of hypertension in younger women. Arch Intern Med 2002, 162:2204-2208.
40. Forman J.P., Rimm E.B., Curhan G.C. Frequency of analgesic use and risk of hypertension among men. Arch Intern Med 2007, 167:394-399. (See comment).
41. Zhang W., Doherty M., Arden N., Bannwarth B., Bijlsma J., Gunther K.P., et al. EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2005, 64:669-681.
42. Jordan K.M., Arden N.K., Doherty M., Bannwarth B., Bijlsma J.W., Dieppe P., et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2003, 62:1145-1155.
43. FDA Drug Safety Information 2009, http://www.fda.gov/Drugs/DrugSafety/informationbydrugclass/ucm165107.htm.
44. Bjordal J.M., Klovning A., Ljunggren A.E., Slordal L. Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: a meta-analysis of randomised placebo-controlled trials. Eur J Pain 2007, 11:125-138.
45. Chan F.K., Wong V.W., Suen B.Y., Wu J.C., Ching J.Y., Hung L.C., et al. Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial. Lancet 2007, 369:1621-1626.
46. Rahme E., Barkun A.N., Toubouti Y., Scalera A., Rochon S., Lelorier J. Do proton-pump inhibitors confer additional gastrointestinal protection in patients given celecoxib?. Arthritis Rheum 2007, 57:748-755.
47. Latimer N., Lord J., Grant R.L., O'Mahony R., Dickson J., Conaghan P.G., et al. Cost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis. BMJ 2009, 339:b2538.
48. Lin J., Zhang W., Jones A., Doherty M. Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trials. BMJ 2004, 329:324-326.
49. Baer P.A., Thomas L.M., Shainhouse Z. Treatment of osteoarthritis of the knee with a topical diclofenac solution: a randomised controlled, 6-week trial. BMC Musculoskelet Disord 2005, 6:44.
50. Bookman A.A., Williams K.S., Shainhouse J.Z. Effect of a topical diclofenac solution for relieving symptoms of primary osteoarthritis of the knee: a randomized controlled trial. CMAJ 2004, 171:333-338.
51. Roth S.H., Shainhouse J.Z. Efficacy and safety of a topical diclofenac solution (Pennsaid) in the treatment of primary osteoarthritis of the knee: a randomized, double-blind, vehicle-controlled clinical trial. Arch Intern Med 2004, 164:2017-2023.
52. Evans J.M., MacDonald T.M. Tolerability of topical NSAIDs in the elderly: do they really convey a safety advantage?. Drugs Aging 1996, 9:101-108.
53. Evans J.M.M., McMahon A.D., McGilchrist M.M., White G., Murray F.E., McDevitt D.G., et al. Topical non-steroidal anti-inflammatory drugs and admission to hospital for upper gastrointestinal bleeding and perforation: a record linkage case-control study. BMJ 1995, 311:22-26.
54. Tugwell P.S., Wells G.A., Shainhouse J.Z. Equivalence study of a topical diclofenac solution (Pennsaid) compared with oral diclofenac in symptomatic treatment of osteoarthritis of the knee: a randomized controlled trial. J Rheumatol 2004, 10:2002-2012.
55. Underwood M., Ashby D., Cross P., Hennessy E., Letley L., Martin J., et al. Advice to use topical or oral ibuprofen for chronic knee pain in older people: randomised controlled trial and patient preference study. BMJ 2008, 336:138-142.
56. Castelnuovo E., Cross P., Mt-Isa S., Spencer A., Underwood M. TOIB study team. Cost-effectiveness of advising the use of topical or oral ibuprofen for knee pain: the TOIB study. Rheumatology 2008, 47:1077-1081.
57. Underwood M., Ashby D., Carnes D., Castelnuovo E., Cross P., Harding G., et al. Topical or oral ibuprofen for chronic knee pain in older people. Health Technol Assess 2008, 12:(22). The TOIB study.
58. Avouac J., Gossec L., Dougados M. Efficacy and safety of opioids for osteoarthritis: a meta-analysis of randomized controlled trials. Osteoarthritis Cartilage 2007, 15:957-965.
59. Ehrich E.W., Davies G.M., Watson D.J., Bolognese J.A., Seidenberg B.C., Bellamy N. Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities Osteoarthritis Index questionnaire and global assessments in patients with osteoarthritis. J Rheumatol 2000, 27:2635-2641.
60. Furlan A.D., Sandoval J.A., Mailis-Gagnon A., Tunks E. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ 2006, 174:1589-1594.
61. Bellamy N., Campbell J., Robinson V., Gee T., Bourne R., Wells G. Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2006, CD005328.
62. Aggarwal A., Sempowski I.P. Hyaluronic acid injections for knee osteoarthritis. Systematic review of the literature. Can Fam Physician 2004, 50:249-256.
63. Arrich J., Piribauer F., Mad P., Schmid D., Klaushofer K., Mullner M. Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis. CMAJ 2005, 172:1039-1043.
64. Bellamy N., Campbell J., Robinson V., Gee T., Bourne R., Wells G. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2005, CD005321.
65. Bellamy N., Campbell J., Robinson V., Gee T., Bourne R., Wells G. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2006, CD005321.
66. Bruyere O., Burlet N., Delmas P.D., Rizzoli R., Cooper C., Reginster J.-Y. Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system. BMC Musculoskelet Disord 2008, 165.
67. Divine J.G., Zazulak B.T., Hewett T.E. Viscosupplementation for knee osteoarthritis: a systematic review. Clin Orthop Rel Res 2007, 455:113-122.
68. Espallargues M., Pons J.M. Efficacy and safety of viscosupplementation with Hylan G-F 20 for the treatment of knee osteoarthritis: a systematic review. Int J Technol Assess Health Care 2003, 19:41-56.
69. Fernandez Lopez J.C., Ruano-Ravina A. Efficacy and safety of intraarticular hyaluronic acid in the treatment of hip osteoarthritis: a systematic review. Osteoarthritis Cartilage 2006, 14:1306-1311.
70. Lo G.H., Lavalley M., McAlindon T., Felson D.T. Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis. JAMA 2003, 290:3115-3121.
71. Maheu E., Ayral X., Dougados M. A hyaluronan preparation (500-730kDa) in the treatment of osteoarthritis: a review of clinical trials with hyalgan. Int J Clin Pract 2002, 56:804-813.
72. Modawal A., Ferrer M., Choi H.K., Castle J.A. Hyaluronic acid injections relieve knee pain. J Fam Pract 2005, 54:758-767.
73. Pagnano M., Westrich G. Successful nonoperative management of chronic osteoarthritis pain of the knee: safety and efficacy of retreatment with intra-articular hyaluronans. Osteoarthritis Cartilage 2005, 13:751-761.
74. Reichenbach S., Blank S., Rutjes A.W., Shang A., King E.A., Dieppe P.A., et al. Hylan versus hyaluronic acid for osteoarthritis of the knee: a systematic review and meta-analysis. Arthritis Rheum 2007, 57:1410-1418.
75. Strand V., Conaghan P.G., Lohmander L.S., Koutsoukos A.D., Hurley F.L., Bird H., et al. An integrated analysis of five double-blind, randomized controlled trials evaluating the safety and efficacy of a hyaluronan product for intra-articular injection in osteoarthritis of the knee. Osteoarthritis Cartilage 2006, 14:859-866.
76. van den Bekerom M.P., Lamme B., Sermon A., Mulier M. What is the evidence for viscosupplementation in the treatment of patients with hip osteoarthritis? Systematic review of the literature. Arch Orthop Trauma Surg 2008, 128:815-823.
77. Wang C.T., Lin J., Chang C.J., Lin Y.T., Hou S.M. Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials. J Bone Joint Surg Am 2004, 86-A:538-545.
78. Bannuru R.R., Natov N.S., Obadan I.E., Price L.L., Schmid C.H., McAlindon T.E. Therapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis: a systematic review and meta-analysis. Arthritis Care Res 2009, 61:1704-1711.
79. Torrance G.W., Raynauld J.P., Walker V., Goldsmith C.H., Bellamy N., Band P.A., et al. A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of Hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (part 2 of 2): economic results. Osteoarthritis Cartilage 2002, 10:518-527.
80. Vlad S.C., LaValley M.P., McAlindon T.E., Felson D.T. Glucosamine for pain in osteoarthritis: why do trial results differ?. Arthritis Rheum 2007, 56:2267-2277.
81. Clegg D.O., Reda D.J., Harris C.L., Klein M.A., O'Dell J.R., Hooper M.M., et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Eng J Med 2006, 354:795-808.
82. Rozendaal R.M., Koes B.W., van Osch G.J.V.M., Uitterlinden E.J., Garling E.H., Willemsen S.P., et al. Effect of glucosamine sulfate on hip osteoarthritis: a randomized trial. Ann Intern Med 2008, 148:268-277.
83. Block J.A., Oegema T.R., Sandy J.D., Plaas A. The effects of oral glucosamine on joint health: is a change in research approach needed?. Osteoarthritis Cartilage 2010, 18:5-11.
84. Towheed T.E., Maxwell L., Anastassiades T.P., Shea B., Houpt J., Robinson V., et al. Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev 2005, CD002946.
85. Moher D. CONSORT: an evolving tool to help improve the quality of reports of randomized controlled trials. Consolidated standards of reporting trials. JAMA 1998, 279:1489-1491.
86. Pavelka K., Gatterova J., Olejarova M., Machacek S., Giacovelli G., Rovati L.C. Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Arch Intern Med 2002, 162:2113-2123.
87. Reginster J.Y., Deroisy R., Rovati L.C., Lee R.L., Lejeune E., Bruyere O., et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet 2001, 357:251-256.
88. Rozendaal R.M., Uitterlinden E.J., van Osch G.J.V.M., Garling E.H., Willemsen S.P., Ginai A.Z., et al. Effect of glucosamine sulphate on joint space narrowing, pain and function in patients with hip osteoarthritis; subgroup analyses of a randomized controlled trial. Osteoarthritis Cartilage 2009, 17:427-432.
89. Sawitzke A.D., Shi H., Finco M.F., Dunlop D.D., Bingham C.O., Harris C.L., et al. The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial. Arthritis Rheum 2008, 58:3183-3191.
90. Bruyere O., Pavelka K., Rovati L.C., Gatterova J., Giacovelli G., Olejarova M., et al. Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trials. Osteoarthritis Cartilage 2008, 16:254-260.
91. Dougados M., Hawker G., Lohmander S., Davis A.M., Dieppe P., Maillefert J.F., et al. OARSI/OMERACT criteria of being considered a candidate for total joint replacement in knee/hip osteoarthritis as an endpoint in clinical trials evaluating potential disease modifying osteoarthritic drugs. J Rheumatol 2009, 36:2097-2099.
92. Borkhoff C.M., Hawker G.A., Kreder H.J., Glazier R.H., Mahomed N.N., Wright J.G. The effect of patients' sex on physicians' recommendations for total knee arthroplasty. CMAJ 2008, 178:681-687.
93. Leeb B.F., Schweitzer H., Montag K., Smolen J.S. A metaanalysis of chondroitin sulfate in the treatment of osteoarthritis. J Rheumatol 2000, 27:205-211.
94. McAlindon T.E., LaValley M.P., Gulin J.P., Felson D.T. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA 2000, 283:1469-1475.
95. Reichenbach S., Sterchi R., Scherer M., Trelle S., Burgi E., Burgi U., et al. Meta-analysis: chondroitin for osteoarthritis of the knee or hip. Ann Intern Med 2007, 146:580-590.
96. Richy F., Bruyere O., Ethgen O., Cucherat M., Henrotin Y., Reginster J.-Y. Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis. Arch Intern Med 2003, 163:1514-1522.
97. Hochberg M.C., Zhan M., Langenberg P. The rate of decline of joint space width in patients with osteoarthritis of the knee: a systematic review and meta-analysis of randomized placebo-controlled trials of chondroitin sulfate. Curr Med Res Opin 2008, Sept 29 (Epub ahead of print).
98. Kahan A., Uebelhart D., De Vathaire F., Delmas P.D., Reginster J.Y. Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2009, 60:524-533.
99. Christensen R., Bartels E.M., Astrup A., Bliddal H. Symptomatic efficacy of avocado-soybean unsaponifiables (ASU) in osteoarthritis (OA) patients: a meta-analysis of randomized controlled trials. Osteoarthritis Cartilage 2008, 16:399-408.
100. Canter P.H., Wider B., Ernst E. The antioxidant vitamins A, C, E and selenium in the treatment of arthritis: a systematic review of randomized clinical trials. Rheumatology 2007, 46:1223-1233.
101. Brien S., Prescott P., Coghlan B., Bashir N., Lewith G. Systematic review of the nutritional supplement Perna Canaliculus (green-lipped mussel) in the treatment of osteoarthritis. Q J Med 2008, 101:167-179.
102. Brien S., Prescott P., Bashir N., Lewith H., Lewith G. Systematic review of the nutritional supplements dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) in the treatment of osteoarthritis. Osteoarthritis Cartilage 2008, 16:1277-1288.
103. Ameye L.G., Chee W.S. Osteoarthritis and nutrition. From nutraceuticals to functional foods: a systematic review of the scientific evidence. Arthritis Res Ther 2006, 8:R127.
104. Usha P.R., Naidu M.U.R. Randomised, double-blind, parallel, placebo-controlled study of oral glucosamine, methylsulfonylmethane and their combination in osteoarthritis. Clin Drug Investig 2004, 24:353-363.
105. Kim L.S., Axelrod L.J., Howard P., Buratovich N., Waters R.F. Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial. Osteoarthritis Cartilage 2006, 14:286-294.
106. Soeken K.L., Lee W.L., Bausell R.B., Agelli M., Berman B.M. Safety and efficacy of S-adenosylmethionine (SAMe) for osteoarthritis. J Fam Prac 2002, 51:425-430.
107. Najm W.I., Reinsch S., Hoehler F., Tobis J.S., Harvey P.W. S-adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: a double-blind cross-over trial. BMC Musculoskelet Disord 2004, 5:6.
108. Christensen R., Bartels E.M., Altman R.D., Astrup A., Bliddal H. Does the hip powder of Rosa canina (rosehip) reduce pain in osteoarthritis patients? - a meta-analysis of randomized controlled trials. Osteoarthritis Cartilage 2008, 16:965-972.
109. Brien S., Lewith G.T., McGregor G. Devil's claw (Harpagophytum procumbens) as a treatment for osteoarthritis: a review of efficacy and safety. J Altern Complement Med 2006, 12:981-993.
110. Chrubasik J.E., Roufogalis B.D., Chrabasik S. Evidence of effectiveness of herbal antiinflammatory drugs in the treatment of painful osteoarthritis and chronic low back pain. Phytother Res 2007, 21:675-683.
111. Solignac M. Mechanisms of action of diacerein, the first inhibitor of interleukin-1 in osteoarthritis. Presse Medicale 2004, 33:t-2.
112. Pavelka K., Trc T., Karpas K., Vitek P., Sedlackova M., Vlasakova V., et al. The efficacy and safety of diacerein in the treatment of painful osteoarthritis of the knee: a randomized, multicenter, double-blind, placebo-controlled study with primary end points at two months after the end of a three-month treatment period. Arthritis Rheum 2007, 56:4055-4064.
113. Pelletier J.P., Yaron M., Haraoui B., Cohen P., Nahir M.A., Choquette D., et al. Efficacy and safety of diacerein in osteoarthritis of the knee: a double-blind, placebo-controlled trial. Arthritis Rheum 2000, 43:2339-2348.
114. Pham T., Le Henanff A., Ravoud P., Dieppe P., Paolozzi L., Dougados M. Evaluation of the symptomatic and structural efficacy of a new hyaluronic acid compound, NRD101, in comparison with diacerein and placebo in a 1 year randomised controlled study in symptomatic knee osteoarthritis. Ann Rheum Dis 2004, 63:1611-1617.
115. Nguyen M., Dougados M., Berdah L., Amor B. Diacerhein in the treatment of osteoarthritis of the hip. Arthritis Rheum 1994, 37:529-536.
116. Louthrenoo W., Nilganuwong S., Aksaranugraha S., Asavatanabodee P., Saengnipanthkul S., Thai Study Group The efficacy, safety and carry-over effect of diacerein in the treatment of painful knee osteoarthritis: a randomised, double-blind, NSAID-controlled study. Osteoarthritis Cartilage 2007, 15:605-614.
117. Fidelix T.S., Soares B.G., Trevisani V.F. Diacerein for osteoarthritis. Cochrane Database Syst Rev 2006, CD005117.
118. Rintelen B., Neumann K., Leeb B.F. A meta-analysis of controlled clinical studies with diacerein in the treatment of osteoarthritis. Arch Intern Med 2006, 166:1899-1906.
119. Dougados M., Nguyen M., Berdah L., Mazieres B., Vignon E., Lequesne M., et al. Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial. Evaluation of the chondromodulating effect of diacerein in OA of the hip. Arthritis Rheum 2001, 44:2539-2547.
120. Lequesne M., Berdah L., Gerentes I. Efficacy and tolerance of diacerhein in the treatment of gonarthrosis and coxarthrosis. Rev Prat 1998, 48(Suppl 5).
121. Hayami T., Pickarski M., Wesolowski G.A., McLane J., Bone A., Destefano J., et al. The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model. Arthritis Rheum 2004, 50:1193-1206.
122. Sondergaard B.C., Oestergaard S., Christiansen C., Tanko L.B., Karsdal M.A. The effect of oral calcitonin on cartilage turnover and surface erosion in an ovariectomized rat model. Arthritis Rheum 2007, 56:2674-2678.
123. Carbone L.D., Nevitt M.C., Wildy K., Barrow K.D., Harris F., Felson D., et al. The relationship of antiresorptive drug use to structural findings and symptoms of knee osteoarthritis. Arthritis Rheum 2004, 50:3516-3525.
124. Bingham C.O., Buckland-Wright J.C., Garnero P., Cohen S.B., Dougados M., Adami S., et al. Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study. Arthritis Rheum 2006, 54:3494-3507.
125. Garnero P., Aronstein W.S., Cohen S.B., Conaghan P.G., Cline G.A., Christiansen C., et al. Relationships between biochemical markers of bone and cartilage degradation with radiological progression in patients with knee osteoarthritis receiving risedronate: the knee osteoarthritis structural arthritis randomized clinical trial. Osteoarthritis Cartilage 2008, 16:660-666.
126. Alexandersen P., Karsdal M.A., Qvist P., Reginster J.Y., Christiansen C. Strontium ranelate reduces the urinary level of cartilage degradation biomarker CTX-II in postmenopausal women. Bone 2007, 40:218-222.
127. Ravn P., Warming L., Christgau S., Christiansen C. The effect on cartilage of different forms of application of postmenopausal estrogen therapy: comparison of oral and transdermal therapy. Bone 2004, 35:1216-1221.
128. Christgau S., Tanko L.B., Cloos P.A., Mouritzen U., Christiansen C., Delaisse J.M., et al. Suppression of elevated cartilage turnover in postmenopausal women and in ovariectomized rats by estrogen and a selective estrogen-receptor modulator (SERM). Menopause 2004, 11:508-518.
129. Manicourt D.H., Azria M., Mindeholm L., Thonar E.J., Devogelaer J.P. Oral salmon calcitonin reduces Lequesne's algofunctional index scores and decreases urinary and serum levels of biomarkers of joint metabolism in knee osteoarthritis. Arthritis Rheum 2006, 54:3205-3211.
130. Bradley J.D., Heilman D.K., Katz B.P., Gsell P., Wallick J.E., Brandt K.D. Tidal irrigation as treatment for knee osteoarthritis: a sham-controlled, randomized, double-blinded evaluation. Arthritis Rheum 2002, 46:100-108.
131. Herrlin S., Hallander M., Wange P., Weidenhielm L., Werner S. Arthroscopic or conservative treatment of degenerative medial meniscal tears: a prospective randomised trial. Knee Surg Sports Traumatol Arthrosc 2007, 15:393-401.
132. Kirkley A., Birmingham T.B., Litchfield R.B., Giffin J.R., Willits K.R., Wong C.J., et al. A randomized trial of arthroscopic surgery for osteoarthritis of the knee. N Eng J Med 2008, 359:1097-1107.
133. Moseley J.B., O'Malley K., Petersen N.J., Menke T.J., Brody B.A., Kuykendall D.H., et al. A controlled trial of arthroscopic surgery for osteoarthritis of the knee. N Eng J Med 2002, 347:81-88.
134. Laupattarakasem W., Laopaiboon M., Laupattarakasem P., Sumananont C. Arthroscopic debridement for knee osteoarthritis. Cochrane Database Syst Rev 2008, CD005118.
135. Ravaud P., Moulinier L., Giraudeau B., Ayral X., Guerin C., Noel E., et al. Effects of joint lavage and steroid injection in patients with osteoarthritis of the knee: results of a multicenter, randomized, controlled trial. Arthritis Rheum 1999, 42:475-482.
136. Arden N.K., Reading I.C., Jordan K.M., Thomas L., Platten H., Hassan A., et al. A randomised controlled trial of tidal irrigation vs corticosteroid injection in knee osteoarthritis: the KIVIS study. Osteoarthritis Cartilage 2008, 16:733-739.
137. Brouwer R.W., Raaij van T.M., Bierma-Zeinstra S.M., Verhagen A.P., Jakma T.S., Verhaar J.A. Osteotomy for treating knee osteoarthritis. Cochrane Database Syst Rev 2007, CD004019.
138. Virolainen P., Aro H.T. High tibial osteotomy for the treatment of osteoarthritis of the knee: a review of the literature and a meta-analysis of follow-up studies. Arch Orthop Trauma Surg 2004, 124:258-261.
139. Griffin T., Rowden N., Morgan D., Atkinson R., Woodruff P., Maddern G. Unicompartmental knee arthroplasty for the treatment of unicompartmental osteoarthritis: a systematic study. ANZ J Surg 2007, 77:214-221.
140. Soohoo N.F., Sharifi H., Kominski G., Liebeuman J.R. Cost-effectiveness analysis of unicompartmental knee arthroplasty as an alternative to total knee arthroplasty for unicompartmental osteoarthritis. J Bone Joint Surg Am 2006, 88:1975-1982.
141. Field M.J., Lohr K.N. Guidelines for clinical practice: from development to use 1992, National Academy Press, Washington DC.
142. Shekelle P.G., Ortiz E., Rhodes S., Morton S.C., Eccles M.P., Grimshaw J.M., et al. Validity of the Agency for Healthcare Research and Quality clinical practice guidelines: how quickly do guidelines become outdated?. JAMA 2001, 286:1461-1467. (See comment).
143. Shekelle P., Eccles M.P., Grimshaw J.M., Woolf S.H. When should clinical guidelines be updated?. BMJ 2001, 323:155-157.
144. Moher D., Tsertsvadze A., Tricco A.C., Eccles M., Grimshaw J., Sampson M., et al. When and how to update systematic reviews. Cochrane Database Syst Rev 2008, MR000023.
145. National Institute for Health and Clinical Excellence Correcting errors in published guidelines. Guidelines Manual 2007, p 89.
146. Olivo S.A., Macedo L.G., Gadotti I.C., Fuentes J., Stanton T., Magee D.J. Scales to assess the quality of randomized controlled trials: a systematic review. Phys Ther 2008, 88:156-175.
147. Berger V.W. Is the Jadad score the proper evaluation of trials?. J Rheumatol 2008, 33:1710-1711. (Comment).
148. Juni P., Altman D.G., Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 2001, 323:42-46.
149. Juni P., Nartey L., Reichenbach S., Sterchi R., Dieppe P.A., Egger M. Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. Lancet 2004, 364:2021-2029.
150. Murphy D.J., Povar G.J., Pawlson L.G. Setting limits in clinical medicine. Arch Intern Med 1994, 154:505-512.
151. McAlindon T., Zucker N.V., Zucker M.O. 2007 OARSI recommendations for the management of hip and knee osteoarthritis: towards consensus?. Osteoarthritis Cartilage 2008, 16:636-637.
152. Buchbinder R., Osborne R.H., Ebeling P.R., Wark J.D., Mitchell P., Wriedt C., et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures. N Eng J Med 06 Aug 2009, 361:557-568.
153. Kallmes D.F., Comstock B.A., Heagerty P.J., Turner J.A., Wilson D.J., Diamond T.H., et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures. N Eng J Med 06 Aug 2009, 361:569-579.
154. Warsi A., LaValley M.P., Wang P.S., Avorn J., Solomon D.H. Arthritis self-management education programs: a meta-analysis of the effect on pain and disability. Arthritis Rheum 2003, 48:2207-2213.
155. Cochrane T., Davey R.C., Matthes Edwards S.M. Randomised controlled trial of the cost-effectiveness of water-based therapy for lower limb osteoarthritis. Health Technol Assess 2005, 9(31).
156. Brosseau L. Efficacy of balneotherapy for osteoarthritis of the knee: a systematic review. Phys Ther Rev 2002, 7:209-222.
157. Nguyen M., Revel M., Dougados M. Prolonged effects of 3 week therapy in a spa resort on lumbar spine, knee and hip osteoarthritis: follow-up after 6 months. A randomized controlled trial. Br J Rheumatol 1997, 36:77-81.
158. Christensen R., Astrup A., Bliddal H. Weight loss: the treatment of choice for knee osteoarthritis? A randomized trial. Osteoarthritis Cartilage 2005, 13:20-27.
159. Brosseau L. Efficacy of transcutaneous electrical nerve stimulation for osteoarthritis of the lower extremities: a meta-analysis. Phys Ther Rev 2004, 9:213-233.
160. Bjordal J.M., Couppe C., Chow R.T., Tuner J., Ljunggren E.A. A systematic review of low level laser therapy with location-specific doses for pain from chronic joint disorders. Aust J Physiother 2003, 49:107-116.
161. Robinson V.A., Brosseau L., Peterson J., Shea B.J., Tugwell P., Wells G. Therapeutic ultrasound for osteoarthritis of the knee. Cochrane Database Syst Rev 2005, CD003132.
162. Kresnik E., Mikosch P., Gallowitsch H.J., Jesenko R., Just H., Kogler D., et al. Clinical outcome of radiosynoviorthesis: a meta-analysis including 2190 treated joints. Nucl Med Commun 2002, 23:683-688.
163. Brosseau L., Judd M.G., Marchand S., Robinson V.A., Tugwell P., Wells G., et al. Thermotherapy for treatment of osteoarthritis. Cochrane Database Syst Rev 2003, CD004522.
164. Bennell K.L., Hinman R.S., Metcalf B.R., Buchbinder R., McConnell J., McColl G., et al. Efficacy of physiotherapy management of knee joint osteoarthritis: a randomised, double blind, placebo controlled trial. Ann Rheum Dis 2005, 64:906-912.
165. Brouwer R.W., Jakma T.S.C., Verhagen A.P., Verhaar J.A.N., Bierma-Zeinstra S.M.A. Braces and orthoses for treating osteoarthritis of the knee (reviews). Cochrane Database Sys Rev 2005, CD004020.
166. Case J.P., Baliunas A.J., Block J.A. Lack of efficacy of acetaminophen in treating symptomatic knee osteoarthritis: a randomized, double-blind, placebo-controlled comparison trial with diclofenac sodium. Arch Intern Med 2003, 163:169-178.
167. Miceli-Richard C., Le B.M., Schmidely N., Dougados M. Paracetamol in osteoarthritis of the knee. Ann Rheum Dis 2004, 63:923-930.
168. Golden H.E., Moskowitz R.W., Minic M. Analgesic efficacy and safety of nonprescription doses of naproxen sodium compared with acetaminophen in the treatment of osteoarthritis of the knee. Am J Ther 2004, 11:85-94.
169. Lee C., Hunsche E., Balshaw R., Kong S.X., Schnitzer T.J. Need for common internal controls when assessing the relative efficacy of pharmacologic agents using a meta-analytic approach: case study of cyclooxygenase 2-selective inhibitors for the treatment of osteoarthritis. Arthritis Care Res 2005, 53:510-518.
170. Zhang W.Y., Li Wan P.A. The effectiveness of topically applied capsaicin. A meta-analysis. Eur J Clin Pharmacol 1994, 46:517-522.
171. Houpt J.B., McMillan R., Wein C., Paget-Dellio S.D. Effect of glucosamine hydrochloride in the treatment of pain of osteoarthritis of the knee. J Rheumatol 1999, 26:2423-2430.
172. McAlindon T., Formica M., Lavalley M., Lehmer M., Kabbara K. Effectiveness of glucosamine for symptoms of knee osteoarthritis: results from an internet-based randomized double-blind controlled trial. Am J Med 2004, 117:643-649.
173. Kalunian K.C., Moreland L.W., Klashman D.J., Brion P.H., Concoff A.L., Myers S., et al. Visually-guided irrigation in patients with early knee osteoarthritis: a multicenter randomized, controlled trial. Osteoarthritis Cartilage 2000, 8:412-418.
174. Nizard R.S., Biau D., Porcher R., Ravaud P., Bizot P., Hannouche D., et al. A meta-analysis of patellar replacement in total knee arthroplasty. Clin Orthop 2005, 196-203.
175. Ethgen O., Bruyere O., Richy F., Dardennes C., Reginster J.-Y. Health-related quality of life in total hip and total knee arthroplasty: a qualitative and systematic review of the literature. J Bone Joint Surg Am 2004, 86:963-974.
176. Garcia Rodriguez L.A., Hernandez-Diaz S. Relative risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal anti-inflammatory drugs. Epidemiology 2001, 12:570-576.
177. Lewis S.C., Langman M.J.S., Laporte J.-R., Matthres N.S., Rawlins M.D., Wiholm B.-E. Dose-response relationships between individual nonaspirin nonsteroidal anti-inflammatory drugs (NSAIDs) and serious upper gastrointestinal bleeding: a meta-analysis based on individual patient data. Br J Clin Pharmacol 2002, 54:320-326.
178. Rexrode K.M., Buring J.E., Glynn R.J., Stampfer M.J., Youngman L.D., Gaziano J.M. Analgesic use and renal function in men. JAMA 2001, 286:315-321.
179. Fored C.M., Ejerblad E., Lindblad P., Fryzek J.P., Dickman P.W., Signorello L.B., et al. Acetaminophen, aspirin, and chronic renal failure. N Eng J Med 2001, 345:1801-1808.
180. Ofman J.J., MacLean C.H., Straus W.L., Morton S.C., Berger M.L., Roth E.A., et al. A metaanalysis of severe upper gastrointestinal complications of nonsteroidal antiinflammatory drugs. J Rheumatol 2002, 29:804-812.
181. Hernandez-Diaz S., Varas-Lorenzo C., Garcia Rodriguez L.A. Non-steroidal antiinflammatory drugs and the risk of acute myocardial infarction. Basic Clin Pharmacol Toxicol 2006, 98:266-274.
182. Hooper L., Brown T.J., Elliott R., Payne K., Roberts C., Symmons D. The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic review. BMJ 2004, 329:948-952.
183. 2antagonists or misoprostol? A meta-analysis of controlled clinical studies. Clin Ter 1991, 139:179-189. (In Italian).
184. Caldwell B., Aldington S., Weatherall M., Shirtcliffe P., Beasley R. Risk of cardiovascular events and celecoxib: a systematic review and meta-analysis. J R Soc Med 2006, 99:132-140.
185. Aldington S., Shirtcliffe P., Weatherall M., Beasley R. Increased risk of cardiovascular events with parecoxib/valdecoxib: a systematic review and meta-analysis. N Z Med J 2005, 118(1226):U1755.
186. Kalso E., Edwards J.E., Moore R.A., McQuay H.J. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 2004, 112:372-380.
187. Coupe V.M.H., Veenhof C., Van Tulder M.W., Dekker J., Bijlsma J.W.J., Van Den Ende C.H.M. The cost effectiveness of behavioural graded activity in patients with osteoarthritis of hip and/or knee. Ann Rheum Dis 2007, 66:215-221.
188. McCarthy C.J., Mills P.M., Pullen R., Richardson G., Hawkins N., Roberts C.R., et al. Supplementation of a home-based exercise programme with a class-based programme for people with osteoarthritis of the knees: a randomised controlled trial and health economic analysis. Health Technol Assess 2004, 8:(46).
189. Patrick D.L., Ramsey S.D., Spencer A.C., Kinne S., Belza B., Topolski T.D. Economic evaluation of aquatic exercise for persons with osteoarthritis. Medical Care 2001, 39:413-424. (Structured abstract).
190. Marshall D.A., Strauss M.E., Pericak D., Buitendyk M., Codding C., Torrance G.W. Economic evaluation of controlled-release oxycodone vs oxycodone-acetaminophen for osteoarthritis pain of the hip or knee. Am J Manag Care 2006, 12:205-214.
191. Elliott R.A., Hooper L., Payne K., Brown T.J., Roberts C., Symmons D. Preventing non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: are older strategies more cost-effective in the general population?. Rheumatology 2005, 10.1093/rheumatology/kei241.
192. Chang R.W., Pellissier J.M., Hazen G.-B. A cost-effectiveness analysis of total hip arthroplasty for osteoarthritis of the hip. JAMA 1996, 275:858-865. (Structured abstract).
193. Rasanen P., Paavolainen P., Sintonen H., Koivisto A.M., Blom M., Ryynanen O.P., et al. Effectiveness of hip or knee replacement surgery in terms of quality-adjusted life years and costs. Acta Orthop 2007, 78:108-115.
194. Lavernia C.J., Guzman J.F., Gachupin G.A. Cost effectiveness and quality of life in knee arthroplasty. Clin Orthop Rel Res 1997, 134-139.